002038.SZ Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 03:04):

Stats
Today's Volume	9.83M
Average Volume	22.14M
Market Cap	8.62B
EPS	CNY0.000390 ( 2023-09-30 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	26.55
ATR14	CNY0.0120 (0.15%)

Volume Correlation

Long: 0.17 (neutral)

Short: -0.62 (weak negative)

Signal:(60.972) Neutral

Beijing SL Pharmaceutical Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Beijing SL Pharmaceutical Correlation - Currency/Commodity

-0.05
( neutral )

0.12
( neutral )

0.00
( neutral )

0.46
( neutral )

0.03
( neutral )

Beijing SL Pharmaceutical Financials

Annual	2022
Revenue:	CNY1.05B
Gross Profit:	CNY893.21M (85.05 %)
EPS:	CNY0.230

Q3	2023
Revenue:	CNY193.12M
Gross Profit:	CNY138.94M (71.95 %)
EPS:	CNY0.000400

Q2	2023
Revenue:	CNY286.93M
Gross Profit:	CNY231.03M (80.52 %)
EPS:	CNY0.110

Q1	2023
Revenue:	CNY296.58M
Gross Profit:	CNY255.38M (86.11 %)
EPS:	CNY0.200

Financial Reports:

No articles found.

Beijing SL Pharmaceutical

Beijing SL Pharmaceutical Co., Ltd., a biopharmaceutical company, researches, develops, produces, and markets genetic engineering and related drugs in the People's Republic of China and internationally. The company's finished formulations includes temozolomide; arsenic trioxide; lenalidomide; docetaxel; paclitaxel; filgrastim Recombinant human granulocyte colony-stimulating factor; recombinant human interleukin-11; recombinant human interleukin-2; thymopentin; vinorelbine bitartrate; hydroxyl-camptothecine; nimustine hydrochloride; asparaginase; PEG L-asparaginase; calcium foliate; recombinant human basic fibroblast growth factor; ciclosporin; mycophenolate mofetil dispersible; ornidazole; adefovir dipivoxil; levofloxacin hydrochloride; azithromycin; ribavirin; tenofovir disoproxil fumarate; valacylovir hydrochloride; lysozyme; stavudine; tropisetron hydrochloride; granisetron hydrochloride; omeprazole; ademetionine 1,4-butanedisulfonate; glutathione; enoxaparin sodium; coenzyme complex; ginkgo biloba extract; simvastatin; telmisartan; naftopidil; nicergoline; zaleplon; cytidine disodium triphosphate; febuxostat; risedronate sodium; loratadine dispersible; somatostatin; octreotide acetate; calcitonin (salmon); paracetamol and tramadol hydrochloride; and etodolac. It also offers active pharmaceutical ingredients. The company was formerly known as Beijing BaiLuyuan Bio-Pharmaceutical Co., Ltd and changed its name to Beijing SL Pharmaceutical Co., Ltd. in 1998. Beijing SL Pharmaceutical Co., Ltd. was founded in 1994 and is based in Beijing, the People's Republic of China.